13 April 2018

The Netherlands X-omics Initiative, led by Radboud university medical center, has received 17 million euros from the Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap for Large-Scale Research Facilities. The X-omics Initiative is one of ten projects awarded by Minister of Education, Culture and Science Ingrid van Engelshoven. A total of 138 million euros has been allocated to facilitate a large-scale research infrastructure in the Netherlands.

In recent years we have seen a spectacular growth of research into genomics, proteomics, metabolomics as well as bioinformatics. The awarding of this X-omics Initiative [pronounced ‘cross-omics’] has given an extra quality incentive to the research structure built up in the Netherlands around genomics (Edwin Cuppen, University Medical Center Utrecht), proteomics (Albert Heck, Utrecht University), metabolomics (Thomas Hankemeier, Leiden University) and integration of data (Alain van Gool, Radboud university medical center). 

Cells in action

Coordinator Alain van Gool: “Our objective is to increase the technological possibilities of all these -omics techniques to a high extent. Also, the higher level of data integration will allow us to map the dynamics among the various -omics levels. As yet, analyses of genomics, proteomics and metabolomics are often separate approaches, hardly connecting with each other. With the X-omics Initiative we are now able to integrate all available data on all levels and to use these data for complex, dynamic analyses of the way in which cells and tissues function as a system. Our newly acquired knowledge of these molecular building blocks of life will allow us to see the contours of cells and tissues in action.” 

Demonstration projects

Combining and improving -omics techniques will contribute to more knowledge of the fundamentals of health and disease, for example regarding cancer, immunoreactions, unique rare diseases and the effect of genetic variations among the Dutch population. The Initiative will set up demonstration projects on various levels to illustrate the power of the -omics techniques in these fields. Hans Clevers and Rene Bernards will study cells and organoids for drugs to cure cancer and the development of resistance to these drugs. Mihai Netea and Han Brunner (both from Radboud university medical center) will study individual patients to look for individual differences regarding rare diseases, while Cornelia van Duijn (Erasmus University Medical Center) and Cisca Wijmenga (University Medical Center Groningen) will analyze population-based genetic variations among the Dutch population. 

National X-omics Infrastructure

Van Gool explicitly states that the X-omics Initiative is a national initiative: “The added value of this initiative lies to a large extent in the cooperation of the top institutes that are already involved in all these -omics parts and data integration. This is the only way to really make a giant leap forward. We have to make this effort together to achieve that, and we commit ourselves to taking the lead in this field worldwide.”

Website X-Omics: link
 
The National Roadmap for Large-Scale Research Facilities encourages setting up or improving large research facilities, enabling the Netherlands to take up an important position in the international research field.
The objective of the National Roadmap for Large-Scale Research Facilities is to invest in Dutch research facilities with an international reputation or in Dutch involvement in building or adapting international research facilities.

More information: link
 

Related news items


To do or not to do? NFU grant for upscaling and expansion

24 April 2019

Call for new projects. Are you a healthcare professional with ideas on how to reduce low-value care? 

read more

Rutger Maas awarded with a Kolff Junior Postdoc Grant of the Dutch Kidney Foundation

23 April 2019

This prestigious Kolff grant allows Rutger to perform a three-year research project into the topic of idiopathic nephrotic syndrome, a group of rare kidney diseases.

read more

Removal of sialic acid from platelets responsible for thrombocytopenia in dengue

23 April 2019

In the PLoS Pathogens Quirijn de Mast and his colleagues showed that excessive binding of the coagulation protein von Willebrand factor leads to removal of sialic acid from platelets and platelet clearance.

read more

High school science education program Immunology and Programming

23 April 2019

International PhD candidates Joshua Gillard, Dorien Feyaerts and Yessica Rodriguez of the Laboratory of Medical Immunology (LMI), recently developed and implemented an exciting 4-day science challenge to teach vaccinology, immunology, and programming at the Lorenz Lyceum high school in Arnhem.

read more

Step-up approach vs open necrosectomy for necrotizing pancreatitis

18 April 2019

Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.

read more

Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients

18 April 2019

In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.

read more